Clinical Trial Detail

NCT ID NCT02159495
Title Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

acute myeloid leukemia

Therapies

Cyclophosphamide

Age Groups: adult

No variant requirements are available.